PF-AtlasClinical Trials › NCT03919604

ECMO for Lung Transplantation in Cystic Fibrosis Patients

Extracorporeal Life Support · Not specified

Registry ID
NCT03919604
Phase
Not specified
Status
Completed
Drug / intervention
Extracorporeal Life Support
Sponsor
Policlinico Hospital
Start
2013-01-01
Enrollment
80
Locations
1

About this trial

Cystic fibrosis (CF) is the most common genetically inherited disease in the Caucasian population. Bilateral lung transplantation (LUTX) is a viable option for these patients. Frequently, the surgical operation of LUTX is complicated by hemodynamic instability, intractable hypoxia and respiratory acidosis. For these reasons, Intraoperative extracorporeal life support - ECLS- is required. Data on predictors of use of intraoperative ECLS in CF patients undergoing LUTX is scarce. Aim of this retrospective observational study was 1) to find possible risk factors at the time of enlistment associated with the intraoperative use of ECLS and 2) to compare the outcomes of CF patients treated with ECLS during LUTX or not.

View NCT03919604 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT03919604 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.